{# ── Billing problem banner: payment failed (past_due) or retries exhausted (unpaid). Pro access is gated off by is_pro until the card is fixed, so prompt the user to update billing. ── #}

Red Flags Detected

  • Delisting (new) — Company received formal Nasdaq delisting notice for bid price non-compliance and is subject to immediate delisting risk after multiple reverse splits.
NASDAQ: JAGX Jaguar Health, Inc. 10-Q

Jaguar secures $16M licensing deal, swings to profit, but faces imminent Nasdaq delisting

Filed May 20, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 15, 2025 · ~2 min read

5 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade JAGX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Feedback
View original filing on SEC.gov

Generated by AI · May 25, 2026 4:42 AM